Defining utility values for patients with tardive dyskinesia

CONCLUSIONS: Utility decrements for TD in this study were slightly larger than previously reported values, potentially due to incorporation of QOL and social consequences in TD health state descriptions. An important limitation of this analysis is that participants' willingness to trade future years of healthy life may not indicate actual willingness to accept the life decrement. These findings can be leveraged to improve cost-effectiveness analyses used to assess the value of treatments for TD.PMID:35045768 | DOI:10.1080/03007995.2021.2022918

Source: Current Medical Research and Opinion - January 20, 2022 Category: Research Authors: Rajeev Ayyagari Debbie Goldschmidt Mo Zhou Rinat Ribalov Stanley N Caroff Sam Leo Source Type: research